Faeth Therapeutics, Inc. FTH

28.00 (1.05) (3.61%) as of 25 Sep
Market cap
$750.7M
P/E
0.0×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Current Ratio
19.69 14.39 5.06 5.81

+8 more quarters

Net Debt/EBITDA
10.15 1.19 4.30 5.20
Debt/Assets
0.00% 0.00% 0.00% 0.00%
Debt/Equity
0.00 0.00 0.00 0.00
Asset Turnover
0.00 0.00 0.00 0.00
Operating CF/Net income
0.98 0.06 0.82 0.78
Capex/Depreciation
0.00 (0.20) 0.00 0.00
Interest Coverage
0.00 0.00 0.00 0.00
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
0.00% 0.00% 0.00% 0.00%
Free Cash Flow per Share
(2.78) (8.29) (3.06) (2.84)
Cash per Share
33.04 156.58 16.80 19.86
Shareholders Equity per Share
30.65 (106.00) 14.74 18.25
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
30.65 (106.00) 14.74 18.25
Free Cash Flow
(15.67) (10.74) (3.86) (3.59)
Working Capital
179.08 190.04 17.26 21.35
Capital Expenditures
0.00 (0.01) 0.00 0.00
Net Current Asset Value
172.31 (138.43) 17.20 21.20
Other line items
Quick Ratio
19.46 14.29 4.98 5.65
Revenue per Share
0.00 0.00 0.00 0.00
Operating CF per Share
(2.78) (8.29) (3.06) (2.84)
Capex per Share
0.00 0.00 0.00 0.00
Average Payables
4.35 5.67 1.36 1.54
Average Assets
110.54 121.83 34.13 40.42
Average Common Equity
100.14 (52.65) 28.49 34.39
Capex to Sales
0.00 0.00 0.00 0.00
Net Profit Margin
0.00% 0.00% 0.00% 0.00%

Fold the line items

Columns are period end dates